Berber, Arturo; Del-Rio-Navarro, Blanca Estela - In: Health Economics Review 9 (2019) 12, pp. 1-9
the immunostimulant, OM-85, was cost-effective in preventing ARTIs in children 2- 6 years old that attended day …-care centers or preschools in Mexico. We performed a systematic review to evaluate the efficacy of OM-85. For costs, we assumed an … immunostimulants and 2.97 ± 0.32 with OM85, during the study period. The mean (25th, 75th percentile) direct costs of ARTIs were 57 …